What are the broader impacts and value from a randomised controlled trial conducted in six public hospital antenatal clinics in Australia? An impact assessment using the Framework to Assess the Impact from Translational health research
Elissa Elvidge(Hunter Medical Research Institute), Shanthi Ramanathan(Hunter Medical Research Institute), Megan E. Jensen(Hunter Medical Research Institute), Andrew Bisits(Royal Hospital for Women), Peter G. Gibson(University Gastroenterology), Andrew Searles(Hunter Medical Research Institute), Kirsten McCaffery(New South Wales Department of Health), Joërg Mattes(John Hunter Hospital), Annelies L. Robijn(Hunter Medical Research Institute), Leonie Callaway(Royal Brisbane and Women's Hospital), John Attia(University of Newcastle Australia), Paul B. Colditz(The University of Queensland), Karen McLaughlin(University of Newcastle Australia), Vanessa E. Murphy(Hunter Medical Research Institute), Alistair Abbott(Nepean Hospital), Helen L. Barrett(The University of Queensland), Michael Hensley(John Hunter Hospital), Melanie Rao(Imperial College London), Sean Seeho(The University of Sydney), Warwick Giles(The University of Sydney), Michael Peek(Australian National University)
Cited by 2
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations
|American Journal of Respiratory and Critical Care Medicine|2009|1.9k
Inflammatory subtypes in asthma: Assessment and identification using induced sputum
|Respirology|2006|939
Clarithromycin Targets Neutrophilic Airway Inflammation in Refractory Asthma
|American Journal of Respiratory and Critical Care Medicine|2007|483
A new perspective on concepts of asthma severity and control
|European Respiratory Journal|2008|475